Join
Live feed
·
PRReleasevia Quantisnow
Atossa Therapeutics Inc. logo

Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher

ByQuantisnow·Wall Street's wire, on your screen.
ATOS· Atossa Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATOS (Atossa Therapeutics Inc.) and more on Quantisnow.